Australia markets closed

Janux Therapeutics, Inc. (JANX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
42.00-0.37 (-0.87%)
At close: 04:00PM EDT
42.00 0.00 (0.00%)
After hours: 04:49PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.18B
Enterprise value 1.55B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)264.19
Price/book (mrq)3.32
Enterprise value/revenue 212.73
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 3.71
52-week change 3240.08%
S&P500 52-week change 323.76%
52-week high 365.60
52-week low 35.65
50-day moving average 348.89
200-day moving average 323.44

Share statistics

Avg vol (3-month) 3818.13k
Avg vol (10-day) 3941.54k
Shares outstanding 551.85M
Implied shares outstanding 652.22M
Float 821.17M
% held by insiders 19.42%
% held by institutions 196.18%
Shares short (15 May 2024) 42.88M
Short ratio (15 May 2024) 43.31
Short % of float (15 May 2024) 411.03%
Short % of shares outstanding (15 May 2024) 45.55%
Shares short (prior month 15 Apr 2024) 43.44M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,610.30%

Management effectiveness

Return on assets (ttm)-8.74%
Return on equity (ttm)-11.50%

Income statement

Revenue (ttm)7.29M
Revenue per share (ttm)0.16
Quarterly revenue growth (yoy)-38.90%
Gross profit (ttm)N/A
EBITDA -70.83M
Net income avi to common (ttm)-55.59M
Diluted EPS (ttm)-1.20
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)651.76M
Total cash per share (mrq)12.57
Total debt (mrq)24.18M
Total debt/equity (mrq)3.69%
Current ratio (mrq)62.09
Book value per share (mrq)12.65

Cash flow statement

Operating cash flow (ttm)-51.5M
Levered free cash flow (ttm)-33.21M